BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2847206)

  • 1. Platelet tritiated imipramine binding and MAO activity in Alzheimer's disease patients with agitation and delusions.
    Schneider LS; Severson JA; Chui HC; Pollock VE; Sloane RB; Fredrickson ER
    Psychiatry Res; 1988 Sep; 25(3):311-22. PubMed ID: 2847206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal platelet 5-hydroxytryptamine uptake and imipramine binding in postnatal dysphoria.
    Hannah P; Adams D; Glover V; Sandler M
    J Psychiatr Res; 1992 Jan; 26(1):69-75. PubMed ID: 1313874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet [3H]-imipramine binding is not modified in Alzheimer's disease.
    Galzin AM; Davous P; Roudier M; Lamour Y; Poirier MF; Langer SZ
    Psychiatry Res; 1989 Jun; 28(3):289-94. PubMed ID: 2548223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet imipramine binding in endogenous depressed patients and controls: relationship to platelet MAO and 5HT uptake during successful imipramine treatment.
    Quintana J
    Psychiatry Res; 1990 Sep; 33(3):229-42. PubMed ID: 2173840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased platelet 3H-imipramine binding and monoamine oxidase B activity in Alzheimer's disease.
    Bonuccelli U; Piccini P; Marazziti D; Cassano GB; Muratorio A
    J Neural Transm Park Dis Dement Sect; 1990; 2(2):139-47. PubMed ID: 2222781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased platelet 3H-imipramine binding in primary major depression compared with depression secondary to medical illness in elderly outpatients.
    Schneider LS; Severson JA; Sloane RB; Fredrickson ER
    J Affect Disord; 1988; 15(2):195-200. PubMed ID: 2851620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet 3H-imipramine binding distinguishes depression from Alzheimer dementia.
    Suranyi-Cadotte BE; Gauthier S; Lafaille F; DeFlores S; Dam TV; Nair NP; Quirion R
    Life Sci; 1985 Dec; 37(24):2305-11. PubMed ID: 2999549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unaltered platelet [3H]-imipramine binding in dementia of the Alzheimer type.
    Weizman R; Dick J; Mosek A; Tyano S; Rehavi M
    Neuropsychobiology; 1988; 19(2):69-72. PubMed ID: 2852311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marked reduction in the number of platelet-tritiated imipramine binding sites in geriatric depression.
    Nemeroff CB; Knight DL; Krishnan RR; Slotkin TA; Bissette G; Melville ML; Blazer DG
    Arch Gen Psychiatry; 1988 Oct; 45(10):919-23. PubMed ID: 2844132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased platelet 3H-imipramine binding in Down's syndrome.
    Tang SW; Berg JM; Bruni J; Davis A
    Psychiatry Res; 1988 Apr; 24(1):67-70. PubMed ID: 2839861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet tritiated imipramine binding in patients suffering from mania.
    Ellis PM; Mellsop GW; Beeston R; Cooke RR
    J Affect Disord; 1991 Jul; 22(3):105-10. PubMed ID: 1655851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet serotonergic markers and aggressive behaviour in healthy subjects.
    Castrogiovanni P; Capone MR; Maremmani I; Marazziti D
    Neuropsychobiology; 1994; 29(3):105-7. PubMed ID: 8022528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences between sodium-dependent and desipramine-defined [3H]imipramine binding in intact human platelets.
    Hrdina PD
    Biol Psychiatry; 1989 Mar; 25(5):576-84. PubMed ID: 2537664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet serotonin uptake and 3H-imipramine binding in panic disorder.
    Norman TR; Sartor DM; Judd FK; Burrows GD; Gregory MS; McIntyre IM
    J Affect Disord; 1989; 17(1):77-81. PubMed ID: 2544638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delusional misidentification and platelet monoamine oxidase.
    Barton JL; Chaparala S; Barton ES; Jackson IV; Davis LG
    Biol Psychiatry; 1980 Apr; 15(2):275-82. PubMed ID: 7417616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood platelets in psychopharmacological research.
    Rotman A
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):135-51. PubMed ID: 6310688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet MAO deamination of serotonin in depressed patients. Changes after imipramine treatment and clinical correlations.
    Quintana J
    Biol Psychiatry; 1988 Jan; 23(1):44-52. PubMed ID: 3337854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imipramine binding sites on platelets of patients with major depressive disorder.
    Carstens ME; Engelbrecht AH; Russell VA; Aalbers C; Gagiano CA; Chalton DO; Taljaard JJ
    Psychiatry Res; 1986 Aug; 18(4):333-42. PubMed ID: 3018818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet 3H-clonidine and 3H-imipramine binding and plasma cortisol level in depression.
    Takeda T; Harada T; Otsuki S
    Biol Psychiatry; 1989 May; 26(1):52-60. PubMed ID: 2541808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tritiated imipramine binding in obsessive-compulsive volunteers and psychiatrically normal controls.
    Black DW; Kelly M; Myers C; Noyes R
    Biol Psychiatry; 1990 Feb; 27(3):319-27. PubMed ID: 2154266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.